Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Income from Continuing Operations (2016 - 2025)

Vycor Medical has reported Income from Continuing Operations over the past 16 years, most recently at 17749.0 for Q4 2025.

  • Quarterly Income from Continuing Operations fell 196.29% to 17749.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 25560.0 through Dec 2025, up 68.77% year-over-year, with the annual reading at 25560.0 for FY2025, 68.77% up from the prior year.
  • Income from Continuing Operations was 17749.0 for Q4 2025 at Vycor Medical, down from 4990.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 261471.0 in Q4 2022 and troughed at 230747.0 in Q1 2021.
  • The 5-year median for Income from Continuing Operations is 24128.0 (2024), against an average of 27757.8.
  • Year-over-year, Income from Continuing Operations tumbled 10463.31% in 2022 and then surged 357.41% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 176391.0 in 2021, then soared by 248.23% to 261471.0 in 2022, then tumbled by 120.55% to 53743.0 in 2023, then soared by 134.3% to 18432.0 in 2024, then plummeted by 196.29% to 17749.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Income from Continuing Operations are 17749.0 (Q4 2025), 4990.0 (Q3 2025), and 25713.0 (Q2 2025).